个性化医疗中的受监管的定价决策和诊断测试选择:在法律框架内导航其影响
Zibin Cui1, Xiangdong Liu2, Zehua Feng3
1School of Management, Guangdong University of Technology, Guangzhou, People's Republic of China.
政府对个性化药品价格的监管影响了药品制造商.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 生物技术是生物技术.
背景情况:
- 个性化医疗需要制药商和诊断公司之间的合作.
- 个性化医疗的政府监管的定价影响了战略决策,包括选择合作伙伴.
研究的目的:
- 调查政府价格监管对个性化医疗的影响.
- 分析监管定价如何影响制药商对诊断合作伙伴的选择.
主要方法:
- 开发一种风格化的分析模型.
- 游戏理论分析的应用.
- 进行数值研究以验证结果.
主要成果:
- 在没有价格监管的情况下,制造商更喜欢高水平的诊断合作伙伴,促进消费者余和社会福利.
- 价格管制改变了选择合作伙伴的标准,取决于患者对治疗失败的敏感性和诊断努力成本.
- 政府定价决策受到患者的敏感性,诊断成本和药物价格比例的影响.
结论:
- 法律框架对于个性化医疗行业至关重要.
- 不受监管的定价促进了有益的合作;受监管的定价需要细微的政策.
- 平衡利益相关者 (患者,制造商,诊断公司) 的利益是有效监管的关键.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Control Governance: Regulatory Bodies and Their Impact
Ethics and Bioethics
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
